Dietary restriction reprograms CD8+ T cell fate to enhance anti-tumour immunity and immunotherapy responses
This preclinical mouse study found that dietary restriction (DR) significantly slows tumor growth by reprogramming CD8+ T cells in the tumor microenvironment. DR promotes the expansion of highly functional, cytotoxic T cells and limits exhausted T cells, primarily by increasing ketone body oxidation. Furthermore, DR synergizes with anti-PD1 immunotherapy, enhancing its anti-tumor effects in these mouse models.